Resonance Health LtdASX: RHT

2026 AGM - Chair Address & MD/CEO Address to Shareholders

· Issued by Resonance Health Ltd via ASX

Filed with ASX · · 9 pages · English

Summary by 6ix AI

The Chairperson highlighted significant growth in revenue and a return to profitability, emphasizing the company's strategic progress and operational cash flow. The Managing Director discussed the company's performance, including revenue growth and the importance of upcoming trials and product developments. The filing also outlines the approval of a capital placement to fund new initiatives and enhance the company's market position.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

ASX Announcement – 19 November 2026 CHAIRPERSON’S ADDRESS & MANAGING DIRECTOR’S ADDRESS TO SHAREHOLDERS 2026 ANNUAL GENERAL MEETING Resonance Health Limited (ASX: RHT) (Resonance or Company) provides the addresses to be delivered by its Chairperson, Mr Aaron Brinkworth, and its Managing...

Resonance Health Ltd on 6ix

Earlier from Resonance Health

Later from Resonance Health

All Resonance Health news releases